Julie Appleby

Visit kff.org to read Julie's bio.

jappleby@kff.org
@Julie_appleby

Suit by Doctors, Hospitals Seeks Change in How Arbitrators Settle Surprise Billing Cases

KFF Health News Original

The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didn’t know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.

Oncology Doctors Say the Build Back Better Act Will Slash Cancer Care Funding — A Skewed Argument

KFF Health News Original

The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.

¿Qué sabemos realmente sobre la eficacia de las vacunas contra covid?

KFF Health News Original

¿Lo esencial? Vacunarse con cualquiera de las tres vacunas disponibles en los Estados Unidos disminuye la posibilidad de infectarse en primer lugar y reduce de manera significativa el riesgo de hospitalización o muerte si se contrae el coronavirus y se desarrolla covid-19.

Insurance Focused on Virtual Visits? The Pros and Cons of a New Twist in Health Plans

KFF Health News Original

New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.

Surprise-Billing Rule ‘Puts a Thumb on the Scale’ to Keep Arbitrated Costs in Check

KFF Health News Original

Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.

Telehealth’s Limits: Battle Over State Lines and Licensing Threatens Patients’ Options

KFF Health News Original

Televisits took off during the worst days of the pandemic, but states are now rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.

Facing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign

KFF Health News Original

The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.

Is Your Living Room the Future of Hospital Care?

KFF Health News Original

In the latest sign that in-home acute care is catching on, two big players — Kaiser Permanente and the Mayo Clinic — announced plans to collectively invest $100 million into the company Medically Home to help scale up their programs.